LEXINGTON, Mass.--(BUSINESS WIRE)--T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced that John McDonough, its CEO, has been invited to speak at two upcoming medical conferences. Mr. McDonough will offer his thoughts on the development and applications of molecular diagnostics at The Medical Development Group (www.meddevgroup.org) Forum and the Molecular Med Tri-Con 2012 (http://www.triconference.com).
